TY  - CONF

T1  - Integrated analysis of abrocitinib for the treatment of adolescents with moderate-to-severe atopic dermatitis from the phase 3 clinical trial program

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2022/01/01

AU  - Paller A

AU  - Eichenfield LF

AU  - Cork MJ

ED  - 

VL  - 87

IS  - 3

SP  - AB72

EP  - AB72

Y2  - 2025/10/26

ER  -